Insider: FUCHS HENRY J President, Worldwide R&D - BIOMARIN PHARMACEUTICAL INC
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 212,117 | 0 | 212,117 |
| Value | $11,282,503.23 | $0.00 | $11,282,503.23 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 03/05/2024 | DDS | 35,341 | Direct | COM | $85.18 | $3,010,395.86 | 212,117 |
| 08/10/2023 | DDS | 12,000 | Direct | COM | $90.43 | $1,085,110.80 | 176,187 |
| 07/20/2020 | DDS | 126,389 | Direct | COM | $130.00 | $16,430,570.00 | 102,995 |
| 07/13/2020 | DDS | 23,011 | Direct | COM | $130.00 | $2,991,430.00 | 102,995 |
| 04/24/2020 | DDS | 13,642 | Direct | COM | $95.34 | $1,300,592.81 | 109,014 |
| 04/24/2020 | DDS | 2,680 | Direct | COM | $97.32 | $260,813.31 | 102,656 |
| 04/24/2020 | DDS | 3,678 | Direct | COM | $96.85 | $356,211.36 | 105,336 |
| 04/20/2020 | DDS | 17,213 | Direct | COM | $90.00 | $1,549,170.00 | 122,656 |
| 03/25/2019 | DDS | 5,932 | Direct | COM | $87.86 | $521,185.52 | 124,536 |
| 03/18/2019 | DDS | 9,597 | Direct | COM | $94.09 | $902,981.73 | 136,304 |
| 03/04/2019 | DDS | 2,196 | Direct | COM | $95.00 | $208,620.00 | 142,504 |
| 08/27/2018 | DDS | 12,500 | Direct | COM | $100.00 | $1,250,000.00 | 130,167 |
| 08/24/2018 | DDS | 12,500 | Direct | COM | $99.00 | $1,237,500.00 | 142,667 |
| 06/14/2018 | DDS | 3,775 | Direct | COM | $90.00 | $339,750.00 | 155,167 |
| 06/14/2018 | DDS | 2,000 | Direct | COM | $90.00 | $180,000.00 | 155,167 |
| 06/14/2018 | DDS | 1,875 | Direct | COM | $90.00 | $168,750.00 | 155,167 |
| 06/14/2018 | DDS | 2,669 | Direct | COM | $90.00 | $240,210.00 | 155,167 |
| 06/14/2018 | DDS | 20,681 | Direct | COM | $90.00 | $1,861,374.79 | 155,167 |
| 04/02/2018 | DDS | 6,650 | Direct | COM | $80.12 | $532,798.00 | 156,676 |
| 04/02/2018 | DDS | 3,350 | Direct | COM | $80.12 | $268,402.00 | 156,676 |
| 01/02/2018 | DDS | 15,000 | Direct | COM | $89.23 | $1,338,400.50 | 133,976 |
| 09/15/2017 | DDS | 15,000 | Direct | COM | $90.50 | $1,357,500.00 | 136,422 |
| 06/19/2017 | DDS | 603 | Direct | COM | $90.00 | $54,270.00 | 136,422 |
| 06/16/2017 | DDS | 5,000 | Direct | COM | $90.00 | $450,000.00 | 145,819 |
| 06/16/2017 | DDS | 9,397 | Direct | COM | $90.00 | $845,730.00 | 136,422 |
| 1 2 3 4 Next Last You are at page 1 of 4 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2025 Zacks Investment Research